Eton Solutions Launches EtonGPT™ Enabled Fund Accounting Platform and Services Targeted at General Partners of Private Equity Firms

Eton Solutions revolutionizes the Private Equity, Real Estate, and Fund of Funds…

Zepp Health Corporation Reports Third Quarter 2024 Unaudited Financial Results

MILPITAS, Calif., Nov. 19, 2024 /PRNewswire/ — Zepp Health Corporation ("Zepp" or…

Xinjiang's Turfan Unveils First Fully Liquid-Cooled Supercharging Station

TURFAN, China, Nov. 19, 2024 /PRNewswire/ — Turfan, a city in Xinjiang…

MiniTool Rolled out ShadowMaker 4.6: Task Name Modification Added

VANCOUVER, BC, Nov. 19, 2024 /PRNewswire/ — MiniTool ShadowMaker 4.6, a significant update…

Statistics Korea, Preparing for the Centenary Population Census with the Launch of the 2024 Address Canvassing

SEOUL, South Korea, Nov. 19, 2024 /PRNewswire/ — Statistics Korea is currently…

Medeze Group Honoured with Industry Champions of the Year Award for Advancements in Longevity Science and Regenerative Healthcare

BANGKOK, Nov. 19, 2024 /PRNewswire/ — Medeze Group Public Company Limited (Medeze…

SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player

SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering…

Everest Medicines Announces NEFECON® Has Received Full Approval from South Korea's Ministry of Food and Drug Safety (MFDS) for the Treatment of Primary IgA Nephropathy

SHANGHAI, Nov. 19, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, "Everest", or…